Mendal Jayme sold $509K of EVER

Mendal Jayme (CEO and President) sold 20,981 shares of EverQuote, Inc. (EVER) at $24.27 ($0.51M total) on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mendal Jayme
Published Sep 17, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Bearish
medium confidence
Mentioned
$EVER
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERBearishLow
01

Why it matters

The sale represents a modest reduction in the CEO's stake, potentially interpreted as a negative sentiment cue by traders.

02

Market read

Insider sales are monitored by investors; this filing may prompt short-term price scrutiny.

03

What to watch

CEO still retains 591,160 shares, representing significant ownership.

Relevance 4/10Novelty 5/10Timing: post filing

Background

EverQuote, Inc. (NASDAQ: EVER) provides insurance quotes online. The filing is a standard Form 4 disclosure of an insider transaction.

Company-level read

Ticker impact

$EVERBearishMedium confidence
Context

CEO Mendal Jayme sold 20,981 shares for $509,208, a Form 4 insider sale disclosed on Sep 15, 2026.

Expected impact

Modest downward pressure in near term

Evidence & confidence

Insider sell by CEO suggests reduced confidence, but size is modest relative to holdings.

Market effects

Minimal impact on insurance brokerage sector; typical insider sell activity.

Limited to US market where EVER trades.

Low

Counterpoint

Insider sell may be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Mendal Jayme

    CEO and President of EverQuote, Inc.

  • EverQuote, Inc.

    Online insurance marketplace listed on NASDAQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.